We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about Tukysa (tucatinib), a prescription medication for HER2-positive breast cancer. This guide covers dosage, administration, duration of treatment, and important considerations for patients in India.

Tukysa, with the active ingredient tucatinib, is a crucial prescription medication used in the treatment of certain types of HER2-positive breast cancer. It belongs to a class of drugs known as kinase inhibitors, which work by interfering with specific proteins that cancer cells need to grow and divide. Tukysa is typically administered in combination with other chemotherapy drugs, namely Herceptin (trastuzumab) and Xeloda (capecitabine), to enhance its effectiveness against this aggressive form of breast cancer. This comprehensive guide will delve into the dosage, administration, and important considerations for patients prescribed Tukysa in India.
Tukysa (tucatinib) is a targeted therapy drug. Its primary mechanism of action is to inhibit the HER2 (human epidermal growth factor receptor 2) pathway, which is overexpressed in HER2-positive breast cancer. By blocking this pathway, Tukysa helps to slow down or stop the growth of cancer cells. It is formulated as a tablet that is taken orally.
The standard dosage of Tukysa for treating certain kinds of HER2-positive breast cancer is 300 mg, taken by mouth twice daily. It is essential to adhere strictly to the dosage prescribed by your doctor. The medication is supplied in tablet form and should be swallowed whole. Do not break, crush, or chew the tablets. If a tablet is broken, do not take it; proceed with your next scheduled dose.
Key Administration Guidelines:
Tukysa is rarely used as a standalone treatment for HER2-positive breast cancer. It is most effective when combined with Herceptin (trastuzumab) and Xeloda (capecitabine). Your doctor will provide specific dosage instructions for each of these medications, and it is crucial to follow them diligently. The synergistic effect of these drugs is vital for managing the disease.
Tukysa is typically prescribed as a long-term treatment. If you and your doctor find that Tukysa is effective and well-tolerated, you may continue taking it for an extended period. The decision to continue or discontinue treatment will be based on your response to the therapy, the presence of any severe side effects, or the progression of your cancer. Regular consultations with your oncologist are essential to monitor your progress and adjust the treatment plan as needed.
In certain situations, your doctor may recommend a dose reduction of Tukysa. This might occur if you experience bothersome side effects or if you are taking other medications that could interact with Tukysa. Your doctor's priority is to find a dosage that effectively manages your cancer while minimizing side effects.
Potential reasons for dose adjustment include:
It is vital to inform your doctor about all medications, supplements, and herbal products you are taking to avoid potential drug interactions.
If you suspect you have taken too much Tukysa, contact your doctor immediately. You can also reach out to the National Poison Control Centre or utilize their online resources. However, if you experience severe symptoms, seek emergency medical attention by calling 108 (or your local emergency number) or going to the nearest hospital emergency room without delay.
Proper storage, understanding expiration dates, and correct disposal of Tukysa are crucial. Refer to the drug's packaging insert for detailed information on how to store your medication, what to do if it expires, and how to dispose of unused medication safely. Generally, medications should be stored at room temperature, away from moisture and heat, and out of reach of children and pets.
It is imperative to consult your doctor or oncologist in the following situations:
A1: Yes, Tukysa can be taken with or without food. However, it's recommended to take it consistently around the same time each day.
A2: If you miss a dose, take it as soon as you remember, unless it is almost time for your next dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose.
A3: Tukysa is a treatment that helps manage HER2-positive breast cancer. It is designed to control the growth of cancer cells and improve outcomes, but it is not considered a cure. Treatment plans are individualized.
A4: Tukysa is often used as a long-term treatment. Your doctor will determine the duration of your treatment based on your response and overall health.
A5: Common side effects can include diarrhea, nausea, fatigue, and abdominal pain. It is crucial to discuss any side effects you experience with your doctor, as they can help manage them and may adjust your dosage if necessary.
Disclaimer: This information is intended for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026